ArticleFrontiers in pediatrics2026
Cumulative secondary systemic metabolic cerebral insults are associated with disease severity and mortality in neonatal hypoxic-ischaemic encephalopathy: a retrospective study.
Article in Frontiers in pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Secondary systemic cerebral metabolic insults (mSSCI), including abnormalities of glucose, sodium, and carbon dioxide, may exacerbate brain injury in neonatal hypoxic-ischaemic encephalopathy (HIE). Their burden and prognostic value remain poorly described. We aimed to assess the frequency of mSSCI and their association with disease severity and mortality. Methods: This single-centre observational study included all newborns admitted for HIE between 2018 and 2020. mSSCI were defined as at least one abnormal blood glucose, sodium, or carbon dioxide value measured from routine samples during the first three days of life. A cumulative mSSCI score was calculated as the sum of the six possible abnormalities. Associations between mSSCI burden, markers of perinatal asphyxia, resuscitation characteristics, and mortality were explored using univariate analyses. Results: Among the 109 newborns, 106 received therapeutic hypothermia within 6 h of birth; 12 developed neonatal seizures, 32 had brain lesions on MRI, and 10 died. 22% experienced no mSSCI, 35% had one, 28% had two, and 15% had three or more. Increasing cumulative mSSCI was significantly associated ( Conclusions: Most newborns with HIE experienced metabolic systemic insults. Accumulation of mSSCI was associated with encephalopathy severity and mortality. Further studies are needed to determine whether mSSCI are markers of illness severity or modifiable targets for neuroprotective strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.